Excited to announce a save the date for the upcoming Keystone Fungal Pathogenesis meeting! Jan 12-15 2026, mark your calendars! 🗓 Program and deadlines in link below #KSFungalPath26 Iliev Lab keystonesymposia.org/conferences/co…

Opinión impopular: Si esto no cambia, ¿quién va a querer dedicarse a la investigación en el futuro? El sistema de posgrado actual es una máquina devora almas, sostenida por la explotación y precarización laboral, q junto a la competencia feroz aleja a las personas de su pasión

We are pleased to announce that Professor Adilia Warris, Co-Director MRC Centre for Medical Mycology, has been elected as a Fellow of the American Academy of Microbiology. Read more here: sites.exeter.ac.uk/medicalmycolog… University of Exeter Faculty of Health & Life Sci Exeter Biosciences University of Exeter News

CMM LATAM visit to MRC Centre for Medical Mycology following the MRC Centre for Medical Mycology ‘s annual retreat.

Be Part of Research - We are recruiting in our Trial of Interferon-gamma in chronic pulmonary aspergillosis bepartofresearch.nihr.ac.uk/trial-details/…

Delighted to announce our publication on the presence of active #candidalysin in #Candida EVs. Great work by Sejeong Lee Antzela Tsavou and our collaborators David Andes Robert Zarnowski Microbial Pathogenicity Mechanisms The Richardson Lab journals.asm.org/doi/epub/10.11…

Attention Bristol immunologists 📢 The abstract deadline for our event, 'The immunology of long-haul disease' on 11 June has been extended! ➡️ Submit your abstract before 7 May to showcase your research in this exciting event at the Bristol Beacon: bit.ly/43wN1gJ

New online! Aspergillus fumigatus biology, immunopathogenicity and drug resistance nature.com/articles/s4157…

📢 Calling all respiratory & infectious disease clinicians: Have a patient with chronic pulmonary aspergillosis (CPA) starting antifungal therapy? They may be eligible for the INCAS Trial, testing interferon-gamma as an adjunct treatment. 🧪 Learn more: ...

❓Curious about how the immune system drives chronic diseases ❔ Join top experts in Bristol on Wednesday 11 June to explore cutting-edge research, including post-viral syndromes and immune dysregulation! Secure your spot today 👉 bit.ly/43wN1gJ

MRC CMM researchers & collaborators highlight the increasing threat of antifungal resistance & a One Health roadmap to respond news.exeter.ac.uk/faculty-of-hea…

Was so glad to present preliminary data about my research in #ISHAM2025 thanks to The Young ISHAM the British Society for Medical Mycology MRC Centre for Medical Mycology and @balloulab for supporting me

Please repost: We have a postdoc position in Fungal Cell Wall Research to study the Malassezia-host interaction interface in the context of atopic dermatitis. ⁦MRC Centre for Medical Mycology⁩; ⁦ECMM⁩; ⁦ISHAM⁩ For more details, visit: jobs.exeter.ac.uk/hrpr_webrecrui…

Great opportunity to network while presenting my fellowship work at the #BSIBristol25 the immunology of long-haul disease, thanks to the British Society for Immunology and the organizers for putting together this meeting and very pleased with the prize! MRC Centre for Medical Mycology

Thanks to new funding from Wellcome we will soon be advertising two postdoc positions! Interested? Please get in touch in the first instance and I'll provide more info on the projects. You can also learn more on our lab website theradlab.co.uk

Fungal test could save people from fatal infection bbc.in/4kRgBTS

I wrote a new book chapter on all things antifungal immunity- good overview for those new to the field and students! Free access with this link until Aug 👇 sciencedirect.com/science/articl…

The exact immune dysfunction in patients with chronic pulmonary aspergillosis is not known. In our recent paper we show that this dysfunction is centered around dendritic cells, leading to reduced IL12 production. ⁦National Aspergillosis Centre⁩ ⁦National Aspergillosis Centre - INCAS trial⁩ pubmed.ncbi.nlm.nih.gov/40503945/

📢 Calling all respiratory & infectious disease clinicians: Have a patient with chronic pulmonary aspergillosis (CPA) starting antifungal therapy? They may be eligible for the INCAS Trial, testing interferon-gamma as an adjunct treatment. 🧪 Learn more: bit.ly/443PQGm

Increasing interest in the role of Aspergillus in bronchiectasis outcomes. Aspergillus serology should become part of routine care, and management should be individualised. National Aspergillosis Centre British Thoracic Society (BTS) James D Chalmers